SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-094200
Filing Date
2018-03-23
Accepted
2018-03-23 16:32:57
Documents
10
Period of Report
2018-05-04
Effectiveness Date
2018-03-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A d508629ddef14a.htm DEF 14A 565932
2 GRAPHIC g508629g03a30.jpg GRAPHIC 27548
3 GRAPHIC g508629g03k29.jpg GRAPHIC 27352
4 GRAPHIC g508629g04c21.jpg GRAPHIC 52235
5 GRAPHIC g508629g17w99.jpg GRAPHIC 36986
6 GRAPHIC g508629g36u31.jpg GRAPHIC 30381
7 GRAPHIC g508629g50q05.jpg GRAPHIC 26386
8 GRAPHIC g508629g69f98.jpg GRAPHIC 25946
9 GRAPHIC g508629img002.jpg GRAPHIC 269771
10 GRAPHIC g508629img003.jpg GRAPHIC 148147
  Complete submission text file 0001193125-18-094200.txt   1445077
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36329 | Film No.: 18710483
SIC: 2834 Pharmaceutical Preparations